460 related articles for article (PubMed ID: 24559803)
21. Low-count whole-body PET/MRI restoration: an evaluation of dose reduction spectrum and five state-of-the-art artificial intelligence models.
Wang YJ; Wang P; Adams LC; Sheybani ND; Qu L; Sarrami AH; Theruvath AJ; Gatidis S; Ho T; Zhou Q; Pribnow A; Thakor AS; Rubin D; Daldrup-Link HE
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1337-1350. PubMed ID: 36633614
[TBL] [Abstract][Full Text] [Related]
22. Imaging of Peritoneal Metastases in Ovarian Cancer Using MDCT, MRI, and FDG PET/CT: A Systematic Review and Meta-Analysis.
Tsili AC; Alexiou G; Tzoumpa M; Siempis T; Argyropoulou MI
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672549
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic accuracy of contrast-enhanced diffusion-weighted MRI for liver metastases of pancreatic cancer: towards adequate staging and follow-up of pancreatic cancer - DIA-PANC study: study protocol for an international, multicenter, diagnostic trial.
Litjens G; Rivière DM; van Geenen EJM; Radema SA; Brosens LAA; Prokop M; van Laarhoven CJHM; Hermans JJ
BMC Cancer; 2020 Aug; 20(1):744. PubMed ID: 32778061
[TBL] [Abstract][Full Text] [Related]
24. Whole-Body Positron Emission Tomography with
Fertitta L; Jannic A; Zehou O; Bergqvist C; Ferkal S; Moryousef S; Lerman L; Mulé S; Luciani A; Bapst B; Ezzedine K; Ortonne N; Itti E; Wolkenstein P
J Invest Dermatol; 2024 Feb; ():. PubMed ID: 38368929
[TBL] [Abstract][Full Text] [Related]
25. Radiation exposure awareness from patients undergoing nuclear medicine diagnostic 99mTc-MDP bone scans and 2-deoxy-2-(18F) fluoro-D-glucose PET/computed tomography scans.
Ribeiro ASF; Husson O; Drey N; Murray I; May K; Thurston J; Oyen WJG
Nucl Med Commun; 2020 Jun; 41(6):582-588. PubMed ID: 32187158
[TBL] [Abstract][Full Text] [Related]
26. Thoracic cavity definition for 3D PET/CT analysis and visualization.
Cheirsilp R; Bascom R; Allen TW; Higgins WE
Comput Biol Med; 2015 Jul; 62():222-38. PubMed ID: 25957746
[TBL] [Abstract][Full Text] [Related]
27. The Role of Whole-Body MRI in Pediatric Musculoskeletal Oncology: Current Concepts and Clinical Applications.
Guimarães JB; da Cruz IAN; Ahlawat S; Ormond Filho AG; Nico MAC; Lederman HM; Fayad LM
J Magn Reson Imaging; 2024 Jun; 59(6):1886-1901. PubMed ID: 34145692
[TBL] [Abstract][Full Text] [Related]
28. COVID-19 pneumonia detected by [
Tsujikawa T; Anzai M; Umeda Y; Tsuyoshi H; Kosaka N; Kimura H; Okazawa H
BJR Case Rep; 2022 Mar; 7(6):20210131. PubMed ID: 35300238
[TBL] [Abstract][Full Text] [Related]
29. Whole body MRI and PET/CT in haematological malignancies.
Lin C; Luciani A; Itti E; Haioun C; Rahmouni A
Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S88-93. PubMed ID: 17921084
[TBL] [Abstract][Full Text] [Related]
30. Multi-task weak supervision enables anatomically-resolved abnormality detection in whole-body FDG-PET/CT.
Eyuboglu S; Angus G; Patel BN; Pareek A; Davidzon G; Long J; Dunnmon J; Lungren MP
Nat Commun; 2021 Mar; 12(1):1880. PubMed ID: 33767174
[TBL] [Abstract][Full Text] [Related]
31. Recent Survey of Effective Doses of F-18 FDG Torso PET/CT in Korea and the Current Recommendations for CT Protocols of PET/CT.
Chong A; Park JM; Pak K; Kim YI; Kwon HW; Lee ES; Nam KP; Lee HY; Lee HJ; Yoo ID; Eo JS; Kim JY; Yoon JK; Kim KM; Kim SM; Kim TS; ;
Nucl Med Mol Imaging; 2020 Oct; 54(5):224-232. PubMed ID: 33088351
[TBL] [Abstract][Full Text] [Related]
32. Effective dose estimation for oncological and neurological PET/CT procedures.
Martí-Climent JM; Prieto E; Morán V; Sancho L; Rodríguez-Fraile M; Arbizu J; García-Velloso MJ; Richter JA
EJNMMI Res; 2017 Dec; 7(1):37. PubMed ID: 28439843
[TBL] [Abstract][Full Text] [Related]
33. How PET/MR Can Add Value For Children With Cancer.
Daldrup-Link H
Curr Radiol Rep; 2017 Mar; 5(3):. PubMed ID: 28695063
[TBL] [Abstract][Full Text] [Related]
34. Advances in medical imaging for the diagnosis and management of common genitourinary cancers.
Bagheri MH; Ahlman MA; Lindenberg L; Turkbey B; Lin J; Cahid Civelek A; Malayeri AA; Agarwal PK; Choyke PL; Folio LR; Apolo AB
Urol Oncol; 2017 Jul; 35(7):473-491. PubMed ID: 28506596
[TBL] [Abstract][Full Text] [Related]
35. Ultrasensitive and multiplexed tracking of single cells using whole-body PET/CT.
Nguyen HTM; Das N; Ricks M; Zhong X; Takematsu E; Wang Y; Ruvalcaba C; Mehadji B; Roncali E; Chan CKF; Pratx G
Sci Adv; 2024 Jun; 10(24):eadk5747. PubMed ID: 38875333
[TBL] [Abstract][Full Text] [Related]
36. Stroma targeting nuclear imaging and radiopharmaceuticals.
Shetty D; Jeong JM; Shim H
Int J Mol Imaging; 2012; 2012():817682. PubMed ID: 22685650
[TBL] [Abstract][Full Text] [Related]
37. Conceptual Approach of Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Chest Diseases.
Coolen J
J Belg Soc Radiol; 2016 Nov; 100(1):10. PubMed ID: 30151439
[TBL] [Abstract][Full Text] [Related]
38. Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring.
Beuthien-Baumann B; Sachpekidis C; Gnirs R; Sedlaczek O
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885129
[TBL] [Abstract][Full Text] [Related]
39. Optimisation of whole-body PET/CT scanning protocols.
Zaidi H
Biomed Imaging Interv J; 2007 Apr; 3(2):e36. PubMed ID: 21614277
[TBL] [Abstract][Full Text] [Related]
40. Imaging features of glucagonoma syndrome: A case report and review of the literature.
Lv WF; Han JK; Liu X; Wang SC; Pan BO; Xu AO
Oncol Lett; 2015 Apr; 9(4):1579-1582. PubMed ID: 25789004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
